Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene - Concepedia

Concepedia

Publication | Closed Access

Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene

23

Citations

14

References

2018

Year

Yasunori Iida, Hiroyuki Wakiguchi, Fumiko Okazaki, Tamaki Nakamura, Hiroki Yasudo, Makoto Kubo, Kazuma Sugahara, Hiroshi Yamashita, Yutaka Suehiro, Naoko Okayama,

Clinical Rheumatology

Nlrp3 GeneAudiologySensorineural DeafnessEarly Canakinumab TherapyArtsHearing Loss

References

	Year	Citations

Page 1